Company News - Canton Biologics

中文

Search

Home

About us

About us

Management Team

Corporate Culture

Services & Solutions

R&D

Antibody Discovery Developability Assessment

Development

Cell Line

Cell Line Development High-Efficiency Expression Vector

Process Analytical Methods Microbial CGT

Manufacturing

Tech Transfer Drug Substance Drug Product Process Characterization Process Validation

Quality & Support

Quality Control Quality Assurance Regulatory Affairs Project Management IP Management

Animal Health

Case Studies & Experience

Technology Platforms

Cell Line Platform

CHOzen® CHOFlow® GS-KO GlycoExpress® Other Commercial Cell Lines Canvector®

Process Development Platform

CHO-Rise® CBoost™ CanPure™ Purification Platform CanCapture™ Membrane Chromatography Platform CanConcentra™ High-Concentration Formulation Platform

Manufacturing Platform

Scale-Plus Technology Biologics Pulsing Production Line

IgMaxTM

News

Company News

Events

Scientific Resources

Video

Join Us

Contact Us

Contact Information

Leave a Message

类别产品类型领域

2026-02-14 15:52:04

A Decade Together, Forging a New Future: Canton Biologics 10th Anniversary Thematic Forum

Guangzhou, January 23, 2026 – On a chilly spring day, over 200 government representatives, industry experts, partners, investors, and employees gathered in Guangzhou Science City to celebrate the 10th anniversary of Guangzhou Canton Biologics Biotechnology Co., Ltd. (“Canton Biologics”), a leading Chinese large-molecule CDMO. Under the theme “A Decade Together, Forging a New Future,” the event traced the company’s journey from a 300‑square‑meter lab to an internationally recognized service provider.

Explore More

2026-03-24 17:37:20

National "Little Giant" Enterprise Officially Awarded, Canton Biologics is the Only Listed Biologics CDMO!

On December 21, 2023, the award ceremony for the fifth batch of National "Little Giant" Enterprises, organized by the Ministry of Industry and Information Technology, concluded successfully.

Explore More

Company News

Events

Scientific Resources

Video

【Event Snapshot】 Smart Manufacturing Breaks Through Bottlenecks in Biologics Production! Qingkun Wei , VP of Canton Biologics, Reveals the Path to Implementing “Smart Manufacturing 4.0”

On September 1, 2025, the 3rd Greater Bay Area Pharmaceutical Industry Manufacturing 4.0 Forum was successfully held at the Shenzhen Convention and Exhibition Center. The forum brought together top industry experts and corporate representatives to discuss the application and innovation of smart manufacturing technologies in the pharmaceutical industry. Mr. Wei Qingkun, Vice President of Canton Biologics, was invited to attend and delivered a keynote speech titled “Application of Smart Manufacturing 4.0 in Biopharmaceuticals,” sharing his insights on the intelligent transformation of biologics manufacturing.

【Event Snapshot】 Cracking the Challenges of CMC Development for Bispecific Antibodies and Complex Recombinant Proteins | Canton Biologics Shines at the 4th BIONNOVA Beijing Innovation Forum

On September 23–24, 2025, the 4th BIONNOVA Beijing Innovation Forum was successfully held in Beijing. The forum focused on full‑chain innovation collaboration and alignment with clinical needs, bringing together more than 3,000 innovation decision‑makers to discuss technological breakthroughs and industrialization pathways in cutting‑edge fields such as antibody drugs, cell and gene therapy.

Greater Bay AreaBiopharmaceutical Innovation and Development Forum

With the theme "Cross-Regional Collaboration, Jointly Promoting Translation," this forum aims to bring together leading experts from academia, industry, and the investment community to discuss cutting-edge advances and collaborative strategies in the field of biotherapeutics. By fostering multi-stakeholder dialogue, the forum will strive to build a bridge between academic innovation and commercial translation, advancing science-driven, patient-centered development of innovative therapies in biomedicine.

Event Recap: Canton Biologics Appears at Sun Yat-sen University Biopharmaceutical Industry Alliance Forum

2024年11月11日，汉腾生物在广州参加了由中山大学主办的“中山大学生物医药产业联盟论坛”。本次论坛汇聚了生物医药领域的顶尖专家和中山大学的优秀硕博士人...

Good News | Canton Biologics Selected for 2025 Guangzhou “Future Unicorn” Innovative Enterprise List

Recently, under the guidance of the Guangzhou Municipal Science and Technology Bureau, the “2025 Discovering Guangzhou Unicorn Innovative Enterprises” list, organized by the Guangzhou Science and Technology Innovation Enterprise Association and co-initiated by institutions including the Guangzhou Industrial Development Research Institute, was officially announced. Following a rigorous selection process, Guangzhou Canton Biologics Technology Co., Ltd. was successfully selected for the 2025 Guangzhou “Future Unicorn” Innovative Enterprise List, owing to its outstanding technological innovation capabilities and high growth potential in the biopharmaceutical CDMO sector.

Subscribe for Updates

About us

About us Management Team Corporate Culture

Services & Solutions

R&D Development Manufacturing Quality & Support Animal Health Case Studies & Experience

Technology Platforms

Cell Line Platform Process Development Platform Manufacturing Platform IgMaxTM

Contact Us

Contact Information Leave a Message

Copyright © 2025 Guangzhou HanTen Biotech Co., Ltd. All Rights Reserved.

Privacy Policy|Yue ICP No. 16115190|Powered by szweb